What is it about?
Ibopamine eyedrops are used in Ophthalmology. This molecule is characterized by a dual mechanism of action, since it acts on both adrenergic and dopaminergic receptors. The adrenergic action is responsible for a marked mydriasis without accomodative paralysis, while the dopaminergic action promotes the production of aqueous humor. Given this dual action, ibopamine may be useful for diagnostic purposes in Ophthalmology. This review article aims at presenting the most intriguing evidence on ibopamine and discusses the profile of patients who may be best suitable to this molecule.
Featured Image
Why is it important?
It is important because this review article aims at presenting the most intriguing evidence on ibopamine and discusses the profile of patients who may be best suitable to this molecule.
Perspectives
The most intriguing perspective is the use of this drug as a not-cycloplegic mydriatic in all our public a/or private offices.
Dr Italo Giuffre'
Catholic University of Rome
Read the Original
This page is a summary of: Ibopamine Eye Drops In Ophthalmology, IOSR Journal of Pharmacy and Biological Sciences, March 2017, IOSR Journals,
DOI: 10.9790/3008-1203042731.
You can read the full text:
Contributors
The following have contributed to this page
